Or 3 years down the road they find out their DNA has been altered.
>Or 3 years down the road they find out their DNA has been altered.
Exactly. In addition to that, I’ve spent a lot of time translating pharma Phase II and III testing for FDA compliance and the scrutiny over ONE adverse event not explainable by a health problem usually shuts them down immediately.
Having 30 and 20-somethings adversely affected by blood clotting would be grounds for rejection of most pre-production pharma research medicines. Even just one.
Maybe they’re worried about birth defects happening to their future children if the father’s DNA has been altered?